PHARMACEUTICAL PERFORMANCE IN THE EVALUATION AND ADHERENCE TO PHARMACOLOGICAL TREATMENT OF TYPE 2 DIABETES MELLITUS. REMUNOM [Internet]. 2025 May 15 [cited 2025 Aug. 27];9(1):1-13. Available from: https://remunom.ojsbr.com/multidisciplinar/article/view/3911